These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 435958)

  • 41. Effect of drug transporter pharmacogenetics on cholestasis.
    Dietrich CG; Geier A
    Expert Opin Drug Metab Toxicol; 2014 Nov; 10(11):1533-51. PubMed ID: 25260651
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Antitubercular drug-induced liver injuries].
    Guo Y; Cui D
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 May; 21(5):308-9. PubMed ID: 11326960
    [No Abstract]   [Full Text] [Related]  

  • 43. Drug-induced liver disease: an overview.
    Zimmerman HJ
    Semin Liver Dis; 1981 May; 1(2):93-103. PubMed ID: 7051299
    [No Abstract]   [Full Text] [Related]  

  • 44. The role of biopsy in the evaluation of inflammatory diseases of the liver.
    Orr W
    Pathol Annu; 1973; 8():21-80. PubMed ID: 4598173
    [No Abstract]   [Full Text] [Related]  

  • 45. [Classification of liver incidents occurring during antitubercular treatments which include rifampicin].
    Blanchon P; Paillas J; Groseille Y; Holler A; Blanchon F
    Ann Med Interne (Paris); 1974 Dec; 125(12):919-22. PubMed ID: 4469954
    [No Abstract]   [Full Text] [Related]  

  • 46. [Drug-induced chronic hepatitis and cirrhosis].
    Dhumeaux D; Mallat A
    Gastroenterol Clin Biol; 1993; 17(5 Pt 2):H31-5. PubMed ID: 8243915
    [No Abstract]   [Full Text] [Related]  

  • 47. Antituberculosis therapy drug-induced liver injury and acute liver failure.
    Devarbhavi H; Dierkhising R; Kremers WK
    Hepatology; 2010 Aug; 52(2):798-9; author reply 799-800. PubMed ID: 20683973
    [No Abstract]   [Full Text] [Related]  

  • 48. Peritoneoscopy during hepatic coma.
    Versieck J; Van Waes L; Barbier F; Demeulenaere L; Vermeire P
    Acta Gastroenterol Belg; 1973 Dec; 36(12):603-8. PubMed ID: 4274712
    [No Abstract]   [Full Text] [Related]  

  • 49. [Rules for the histological evaluation of drug-induced liver lesions].
    Bianchi L; De Groote J; Desmet V; Gedigk P; Korb G; Popper H; Poulsen H; Scheuer PJ; Schmid M; Thaler H; Wepler W
    Dtsch Med Wochenschr; 1975 Aug; 100(35):1746-50. PubMed ID: 1157673
    [No Abstract]   [Full Text] [Related]  

  • 50. Drug-induced liver disease.
    Kim JW; Hattori A; Phongsamran PV
    Crit Care Nurs Clin North Am; 2010 Sep; 22(3):323-34. PubMed ID: 20691383
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Danger of liver damage in modern antitubercular treatment].
    Kozma D; Lapis K; Debreczeni L
    Prax Klin Pneumol; 1983 Oct; 37 Suppl 1():479-81. PubMed ID: 6647279
    [No Abstract]   [Full Text] [Related]  

  • 52. Differential diagnosis of jaundice in the older age group.
    Spellberg MA; Garau J
    Geriatrics; 1972 Oct; 27(10):100-8. PubMed ID: 5074232
    [No Abstract]   [Full Text] [Related]  

  • 53. [Severe hepatitis induced by chemotherapy with antitubercular agents in childhood. 2 cases].
    Chapoy P; Ferracci JP; Mattei JF; Granjon B; Louchet E
    Pediatrie; 1978; 3(7):637-45. PubMed ID: 740454
    [No Abstract]   [Full Text] [Related]  

  • 54. [Chemotherapy and liver metabolism].
    von Oldershausen HF
    Prax Pneumol; 1974 Dec; 28 Suppl():982-94. PubMed ID: 4456374
    [No Abstract]   [Full Text] [Related]  

  • 55. Drugs and the liver.
    Kolts BE; Langfitt M
    Compr Ther; 1984 Dec; 10(12):55-70. PubMed ID: 6097399
    [No Abstract]   [Full Text] [Related]  

  • 56. [Histopathologic observations on acute liver lesions in patients taking Nizoralt (ketokonazol)].
    Kendrey G; Kovács M
    Morphol Igazsagugyi Orv Sz; 1988 Oct; 28(4):292-7. PubMed ID: 3185578
    [No Abstract]   [Full Text] [Related]  

  • 57. [Galactosamine-hepatitis and anit-cholestasis. Liver damage caused by D-galactosamine-hydrochloride and 1-naphthyl-isothiocyanate (anit)].
    Leinweber B
    Fortschr Med; 1973 Jun; 91(18):792-6. PubMed ID: 4723864
    [No Abstract]   [Full Text] [Related]  

  • 58. [The hepatotoxicity of antitubercular agents].
    Alegre Martín J; Fernández de Sevilla T
    An Med Interna; 1992 Nov; 9(11):523-5. PubMed ID: 1467398
    [No Abstract]   [Full Text] [Related]  

  • 59. [Liver damage caused by laxatives. A contribution to the hepatotoxicity of 4,4'-(2-quinolylmethylene)-diphenol-hydrochloride].
    Wiegelmann W; Borchard F; Irmscher K
    Arzneimittelforschung; 1975 Jun; 25(6):849-51. PubMed ID: 169854
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Adverse drug effects on the liver in patients with tuberculosis].
    Polunina TE; Polunin VI; Grishin VK
    Voen Med Zh; 1987 Oct; (10):67-8. PubMed ID: 3433693
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.